L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey

Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance

(2016) Ming Lu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease

(2016) Alessandra Nicoletti et al.   JOURNAL OF NEUROLOGY

Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study

(2016) Per Svenningsson et al.   MOVEMENT DISORDERS

Falls in ambulatory non-demented patients with Parkinson’s disease

(2015) Olivier Rascol et al.   JOURNAL OF NEURAL TRANSMISSION

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort

(2015) Pietro-Luca Ratti et al.   PARKINSONISM & RELATED DISORDERS

Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries

(2014) Marlene C. Hechtner et al.   PARKINSONISM & RELATED DISORDERS

Prevalence, Determinants, and Effect on Quality of Life of Freezing of Gait in Parkinson Disease

(2014) Santiago Perez-Lloret et al.   JAMA Neurology

Clinical Determinants of Health-related Quality of Life in Mexican Patients with Parkinson’s Disease

(2013) Mayela Rodríguez-Violante et al.   ARCHIVES OF MEDICAL RESEARCH

Exenatide and the treatment of patients with Parkinson’s disease

(2013) Iciar Aviles-Olmos et al.   JOURNAL OF CLINICAL INVESTIGATION

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease

(2013) C. Warren Olanow et al.   MOVEMENT DISORDERS

The relationship between the phenotype of Parkinson's disease and levodopa-induced dyskinesia

(2013) Yu-han Zhang et al.   NEUROSCIENCE LETTERS

Resting Tremor in Parkinson Disease

(2011) Stefan Kipfer   ARCHIVES OF NEUROLOGY

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort

(2011) S. Perez-Lloret et al.   EUROPEAN JOURNAL OF NEUROLOGY

Wearing-off scales in Parkinson's disease: Critique and recommendations

(2011) Angelo Antonini et al.   MOVEMENT DISORDERS

Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations

(2011) Pablo Martinez-Martin et al.   MOVEMENT DISORDERS

Health-related quality of life and its determinants in Parkinson’s disease: Results of an Italian cohort study

(2011) Yaroslav Winter et al.   PARKINSONISM & RELATED DISORDERS

Patient perception of dyskinesia in Parkinson's disease

(2010) S. W. Hung et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

(2010) Carlo Colosimo et al.   MOVEMENT DISORDERS

Classifying risk factors for dyskinesia in Parkinson’s disease

(2010) J.C. Sharma et al.   PARKINSONISM & RELATED DISORDERS

Quality of Life in Relation to Mood, Coping Strategies, and Dyskinesia in Parkinson's Disease

(2009) Sébastien Montel et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study

(2009) Yaroslav Winter et al.   JOURNAL OF NEUROLOGY

Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study

(2009) Yaroslav Winter et al.   PARKINSONISM & RELATED DISORDERS

SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures

(2009) Carlos A. Brown et al.   QUALITY OF LIFE RESEARCH

Quality of life in Parkinson's disease: The relative importance of the symptoms

(2008) Shibley Rahman et al.   MOVEMENT DISORDERS